Abbott aims to roll out its continuous glucose monitor that also tracks ketone levels for diabetic ketoacidosis by the end of the year.
Abbott Laboratories (NYSE:ABT) benefits each time a patient replaces a glucose sensor. Continuous glucose monitoring, or CGM, ...
New study finds continuous glucose monitors improve blood sugar control in people with type 2 diabetes who don't use insulin.
Continuous glucose monitors can dramatically improve blood sugar control among people with type 2 diabetes who aren’t yet ...
The FitBit Air has been out for a few months now, but two of its biggest features are supposed to be arriving this month.
For people living with diabetes, figuring out how different foods affect their blood sugar can feel like a never-ending ...
How big is the sensor patch market, and why is it growing so fast? The global sensor patch market is valued at USD 7.9 ...
Abbott Laboratories (NYSE:ABT) received CE Mark for its Cologuard Plus colorectal cancer test under the EU In Vitro ...
More than 30 million Americans live with Type 2 diabetes, and for many, managing it feels like a guessing game. Many also ...
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don ...
The newly cleared system is compatible with select continuous glucose monitors, including FreeStyle Libre 3 Plus and ...
Partnership combines Abbott's Lingo continuous glucose monitor with Berry Street's insurance-covered registered dietitian support, helping consumers translate glucose insights into healthier behaviors ...